KINROSS GOLD CORP (KGC)

CA4969024047 - Common Stock

4.82  +0.12 (+2.55%)

After market: 4.8299 +0.01 (+0.21%)


Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KGC. KGC was compared to 951 industry peers in the Metals & Mining industry. KGC has a bad profitability rating. Also its financial health evaluation is rather negative. KGC is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

1

The Piotroski-F score of KGC is 6.00. This is a neutral score and indicates average health and profitability for KGC.
KGC has a Return On Assets of 0.08%. This is below the industry average of 7.46%. 100% of the industry peers outperform KGC.

KGC has a Return On Equity of 0.15%. This is below the industry average of 11.95%. 100% of the industry peers outperform KGC.
KGC has a Profit Margin of 0.24%. This is below the industry average of 13.37%. 100% of the industry peers outperform KGC.
VS Industry

ROA (0.08%) VS Industry: 0% outperformed.

0.08
96.57

ROE (0.15%) VS Industry: 0% outperformed.

0.15
143.82

Profit Margin (0.24%) VS Industry: 0% outperformed.

0.24
1,224.45

Valuation

Valuation Rating

3

KGC's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average industry price book ratio of 1.59, KGC is valued rather cheaply
The Price/Earnings Ratio is 20.08, which indicates a rather expensive current valuation of KGC.
With a Forward Price/Earnings Ratio of 17.60, KGC is valued rather expensively.

When comparing the current price to the book value of KGC, we can conclude it is valued correctly. It is trading at 1.01 times its book value.
Compared to an average industry Enterprise Value to EBITDA ratio of 6.84, KGC is valued in line with its industry peers.
KGC's Price/Earning Ratio is slightly more expensive than the industry average, which is at 14.50.
VS Industry

Price/Earnings (20.08) VS Industry: 37% outperformed.

490.50
1.17

Price/Book (1.01) VS Industry: 68% outperformed.

238.39
0.03

Enterprise Value/ EBITDA (5.53) VS Industry: 59% outperformed.

576.92
0.26

Growth

Growth Rating

2

Measured over the past 5 years, KGC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.44% on average per year.
The Revenue has grown by 16.43% in the past year. This is quite good.
The Earnings Per Share is expected to decrease by -1.89% on average over the next 5 years.
Measured over the past 5 years, KGC shows a small growth in Revenue. The Revenue has been growing by 0.90% on average per year.

Based on estimates for the next 5 years, KGC will show a decrease in Revenue. The Revenue will decrease by -1.30% on average per year.
The earnings per share for KGC have decreased strongly by -26.97% in the last year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS10.44% -12.22% -26.97% 21.24% 9.13% 11.6% -1.89%
Revenue0.9% -0.4% 16.43% 10.62% 2.41% 1.09% -1.3%

Health

Health Rating

1

KGC has a Current Ratio of 1.72. This is a normal value and indicates that KGC is financially healthy and should not expect problems in meeting its short term obligations.
KGC has a Piotroski-F score of 6.00. This indicates an average health and profitability for KGC.
Compared to an average industry Current Ratio of 2.61, KGC is worse placed to pay its short term obligations than its industry peers.
A Quick Ratio of 0.71 indicates that KGC may have some problems paying its short term obligations.

When comparing the Quick Ratio of KGC to the average industry Current Ratio of 2.16, KGC is less able to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.00, KGC is requires more financing than its industry peers. 91% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 0.16, we must say that KGC is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of KGC to the average industry Altman-Z score of 2.40, KGC is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0.37) VS Industry: 9% outperformed.

9.62
0.00

Quick Ratio (0.71) VS Industry: 22% outperformed.

0.00
178.59

Current Ratio (1.72) VS Industry: 37% outperformed.

0.00
178.59

Altman-Z (0.16) VS Industry: 34% outperformed.

-2,971.44
2,275.05

Dividend

Dividend Rating

3

KGC has been paying a dividend for over 5 years, so it has already some track record.
With a Yearly Dividend Yield of 2.47%, KGC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.18, KGC has a dividend in line with its industry peers.

KGC's Dividend Yield is comparable with the S&P500 average which is at 2.71.
The dividend of KGC decreases each year by -4.84%.
1726.14% of the earnings are spent on dividend by KGC. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (2.47%) VS Industry: 52% outperformed.

0.23
27.57

KINROSS GOLD CORP

NYSE:KGC (6/8/2023, 5:05:57 PM)

After market: 4.8299 +0.01 (+0.21%)

4.82

+0.12 (+2.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-09 2023-05-09/amc
Earnings (Next)08-02 2023-08-02/amc
Inst Owners52.21%
Inst Owner Change-7.44%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.92B
Analysts80
Price Target6.52 (35.27%)
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Dividend Growth(5Y)-4.84%
DP1726.14%
Div Incr YearsN/A
Div Non Decr Years2
Ex-Date05-31 2023-05-31 (0.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.31%
Min EPS beat(2)20.46%
Max EPS beat(2)60.17%
EPS beat(4)2
Avg EPS beat(4)-0.64%
Min EPS beat(4)-63.24%
Max EPS beat(4)60.17%
Revenue beat(2)2
Avg Revenue beat(2)2.26%
Min Revenue beat(2)0.39%
Max Revenue beat(2)4.13%
Revenue beat(4)2
Avg Revenue beat(4)-9.78%
Min Revenue beat(4)-25.07%
Max Revenue beat(4)4.13%
PT rev (1m)8.24%
PT rev (3m)8.67%
EPS NQ rev (1m)21.71%
EPS NQ rev (3m)9.64%
EPS NY rev (1m)0%
EPS NY rev (3m)1.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.92%
Valuation
Industry RankSector Rank
PE 20.08
Fwd PE 17.6
P/S 1.61
P/FCF 16.11
P/OCF 4.75
P/B 1.01
P/tB 1.01
EV/EBITDA 5.53
EPS(TTM)0.24
EY4.98%
EPS(NY)0.27
Fwd EY5.68%
FCF(TTM)0.3
FCFY6.21%
OCF(TTM)1.02
OCFY21.07%
SpS3
BVpS4.8
TBVpS4.8
PEG (NY)0.95
PEG (5Y)1.92
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.15%
ROIC 5.23%
ROICexc 5.51%
ROICexgc 5.51%
OM 16.85%
PM 0.24%
GM 25.18%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.64%
ROIC(5y)6.24%
ROICexc(3y)8.37%
ROICexc(5y)6.79%
ROICexgc(3y)8.49%
ROICexgc(5y)6.9%
ROICexcg growth 3Y-6.11%
ROICexcg growth 5Y4.67%
ROICexc growth 3Y-5.47%
ROICexc growth 5Y5.2%
OM growth 3Y0.02%
OM growth 5Y11.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.9%
GM growth 5Y2.64%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 7.44
Debt/EBITDA 1.9
Cap/Depr 107.85%
Profit Quality 4175%
Current Ratio 1.72
Quick Ratio 0.71
Altman-Z 0.16
F-Score6
WACC8.5%
ROIC/WACC0.65
Cap/Depr(3y)105.95%
Cap/Depr(5y)120.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-26.97%
EPS 3Y-12.22%
EPS 5Y10.44%
EPS growth Q2Q18.33%
EPS Next Y21.24%
EPS Next 2Y9.13%
EPS Next 3Y11.6%
EPS Next 5Y-1.89%
Revenue growth 1Y16.43%
Revenue growth 3Y-0.4%
Revenue growth 5Y0.9%
Revenue growth Q2Q32.59%
Revenue Next Year10.62%
Revenue Next 2Y2.41%
Revenue Next 3Y1.09%
Revenue Next 5Y-1.3%
EBIT growth 1Y24.16%
EBIT growth 3Y-0.38%
EBIT growth 5Y12.68%
EBIT Next Year235.31%
EBIT Next 3Y42.67%
EBIT Next 5Y25.3%
FCF growth 1Y-63.58%
FCF growth 3Y33.67%
FCF growth 5Y39.56%
OCF growth 1Y-35.67%
OCF growth 3Y-5%
OCF growth 5Y1.99%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA